The American Food and Bars Administration (FDA) has announced withdrawal from the supplement market Preworkou's research after laboratory analysis revealed the presence of a stimulating substance that could cause serious cardiovascular problems.
The announcement was released by the FDA on October 7th 2026, while the production company Leader Formulas had launched the withdrawal procedure the previous day.
According to [the FDA's official announcement] https://www.fda.gov/sidety/recalls-market-withdrawals-sight-allautts/leaulas-ILuc-volutary-muneationationable-recalled-prevalves-prewut-duut-denence-13m?source=chat.com), the product contains 1.3-cymajant <x0, as an intensive blood pressure that can increase blood pressure and difficulties in chest, heart attacks, and heart attacks.
The solution was distributed throughout the United States through physical shops and internet sales, from January 29, 2025 to May 25, 2026.
Authorities have urged consumers who have bought the product to immediately disrupt its use.
What products have been attracted to the market?
According to FDA, withdrawal includes a series of supplement production Preworkout, which is traded as a product for energy growth and improved physical performance during exercise.
The product is sold in plastic embalmings of 450 grams, red and black, and the figure of a rhino on the cover.
The attraction includes three options: Rainbow Twist, Electric Lemonade and Berry Mojito.
All three variants belong to a production series of 260327-4.
The FDA has also published identification codes of products. Rainbow Twist has the UPC code 710154236506, Electric Lemonade 710143236513, while Berry Mojito 7154236544.
Consumers can check this data in the ambulance to determine whether the product they bought is involved in the attraction.
Authorities have not announced that all company products are dangerous. The move is specifically linked to the identified Preworcous series.
WHAT is DMAA, and why is it considered dangerous?
DMAA is a stimulating substance that has been used in products to increase sports performance and weight loss.
According to [FDA guidelines for the DMAA substance] https://www.fda.gov/food/information-syct-dietary-supplement-edients-and-other-substances/dmaa-producings-marketed-duletary-supmental?"source=chatgt.com), it can narrow blood vessels and arteries, causing the rise of the arts tension.
This effect can increase the risk of heart rate disorders, breathing difficulties, and other cardiovascular complications.
The FDA warns that danger can be particularly disturbing when DMAA combines with other stimulants, including caffeine.
The American authority stresses that there is no credible scientific evidence demonstrating the safety of the DMA consumption in food supplements.
Substance has been traded on several occasions even with the appointment of geranium extract, though The FDA says that there is no reliable evidence that it is naturally found in the plant.
For this reason, products traded as food supplements containing DMAA is considered illegal in the United States.
However, the presence of this substance does not mean that any person who consumed the product will experience health problems.
The danger depends on various factors, including the consumption and health of the individual.
Are cases of a heart attack reported?
Until the announcement's release, the company Leader Formulas had not received reports of unwanted health effects related to the drawing series.
This is confirmed in the company's statement, published by the FDA.
However, lack of reporting does not mean that the product is safe.
The retirement decision was taken after FDA laboratory tests confirmed the DMA's presence.
Authorities have clarified that this substance could cause serious complications, even though no concrete cases of damage were reported from the series involved in the announcement.
The company has started contacting distributors and clients for organising product returns.
What should those who have used it do?
FDA recommends that consumers stop immediately using RATIO Re Preworcow if their product belongs to the attraction series.
The product can be returned to the purchase site for full repurchasation.
People who have experienced post-use health problems should consult a health professional.
If serious symptoms, such as chest pain, severe breathing difficulties, or a loss of consciousness, should immediately be sought urgent medical help.
The FDA has also urged consumers and health professionals to report the alleged effects through the American system MedWatch.
Reports help authorities identify potential problems with product safety and take additional measures when necessary.
Warning for other supplements users as well
Case RATIO RE Preworcout turns attention to the security of supplements that promise greater energy, physical stability and improved performance during training.
The FDA has warned early on about other products containing DMAA, including supplements traded for weakening and boosting energy.
In May 2026, the American authority had issued a specific warning for Preworcou RATIO after laboratory tests had identified DMAA on the product.
The withdrawal announced in October represents a further step, with the identification of the production series and the procedure for the return of sold products.
Food security experts stress the importance of controlling official components and warnings before using sporting supplements.
The fact that a product is sold online or in specialized stores does not automatically guarantee its safety.
In the United States, food supplements are not subject to the same process of FDA preliminary approval as drugs.
For consumers, the latest announcement is a reminder that products used to improve physical performance can contain substances with serious health consequences.
For now, confirmed withdrawal is linked to the American market. There is no verified announcement that the products of this series have been officially distributed to European markets.
However, those who bought it RATIO New Preworcout via the internet by international vendors should control the number of the series and follow the FDA warning.
